FindTrial
Sign In

Studying the blood infection of candida in critically ill patients, its occurrence, its resistance pattern, comorbidities, and other risk factors.

incidence of candidemia in critically ill patients: species characterisation, antifungal resistance pattern, comorbiditites and other risk factors: A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/083368
Enrollment
50
Registered
2025-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Department of Anaesthesiology and Critical Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted in the Intensive care unit under the Department of Anaesthesiology with associated risk factors

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study Patients with existing candidemia

Design outcomes

Primary

MeasureTime frame
To determine the epidemiology of candidemia, species identification and their antimicrobial resistance patternTimepoint: 1 week after ICU admission—

Secondary

MeasureTime frame
antifungal response and mortalityTimepoint: 7, 10 days of start of antifungal and at discharge—

Countries

India

Contacts

Public ContactDr Monica Kohki

King Georges Medical University

monica_kohli@rediffmail.com9839041228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026